These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 26591342)

  • 1. [Kidney diseases and metabolic disorders--basics and applications required for general physicians. Topics: IV. Uric acid metabolic disorder (relationship between liyperuricemia and CKD-CVD)].
    Ohno I
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):931-7. PubMed ID: 26591342
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: V. Acid-base disorders and kidney disease].
    Kaname S
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):938-47. PubMed ID: 26591343
    [No Abstract]   [Full Text] [Related]  

  • 3. [Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: VII. Abnormality in phosphate metabolism].
    Hamano T
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):953-9. PubMed ID: 26591345
    [No Abstract]   [Full Text] [Related]  

  • 4. [Kidney diseases and metabolic disorders-Basics and applications required for general physicians. Topics: II. Disorder of carbohydrate metabolism].
    Ogata K; Matsumoto T; Ode K; Shinmamura Y; Inoue K; Taniguchi Y; Horino T; Terada Y
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):917-22. PubMed ID: 26591340
    [No Abstract]   [Full Text] [Related]  

  • 5. [Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: I. Disorders of water balance and sodium metabolism].
    Ota T; Uchida S
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):906-16. PubMed ID: 26591339
    [No Abstract]   [Full Text] [Related]  

  • 6. [Kidney Diseases and Metabolic Disorders--Basics and Applications Required for General Physicians].
    Narita I
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):901-5. PubMed ID: 26591338
    [No Abstract]   [Full Text] [Related]  

  • 7. Relationship between serum uric acid level and cardiometabolic risks in nondiabetic patients with schizophrenia.
    Rajan S; Zalpuri I; Harrington A; Cimpeanu C; Song X; Fan X
    Int Clin Psychopharmacol; 2016 Jan; 31(1):51-6. PubMed ID: 26550697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uric acid and cardiovascular disease: a renal-cardiac relationship?
    Culleton BF
    Curr Opin Nephrol Hypertens; 2001 May; 10(3):371-5. PubMed ID: 11342800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and renal effects of hyperuricaemia and gout.
    Viazzi F; Leoncini G; Pontremoli R
    Reumatismo; 2012 Jan; 63(4):253-62. PubMed ID: 22303532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relation of serum uric acid with metabolic risk factors in asymptomatic middle-aged Brazilian men.
    Desai MY; Santos RD; Dalal D; Carvalho JA; Martin DR; Flynn JA; Nasir K; Blumenthal RS
    Am J Cardiol; 2005 Apr; 95(7):865-8. PubMed ID: 15781018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Kidney diseases and metabolic disorders--Basics and applications required for general physicians. Topics: IX. Impaired drug metabolism].
    Usui J
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):967-74. PubMed ID: 26591347
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of the causes of persistent hyperuricaemia.
    Emmerson BT
    Lancet; 1991 Jun; 337(8755):1461-3. PubMed ID: 1675330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uric acid and cardiovascular-renal disease risk. Insights from a human model opposite to hypertension.
    Maiolino G; Pagnin E; Plebani M; Davis PA; Calò LA
    Int J Cardiol; 2016 Jun; 212():18-9. PubMed ID: 27016704
    [No Abstract]   [Full Text] [Related]  

  • 14. [Concentration of uric acid in the serum. Interrelationship between uric acid and age, weight, height, serum lipids, liver function, glucose tolerance as well as basic disorders].
    Matzkies F; Brunner C; Berg G
    Fortschr Med; 1974 Nov; 92(32):1311-7. PubMed ID: 4457436
    [No Abstract]   [Full Text] [Related]  

  • 15. [KDIGO guidelines for the diagnosis and treatment of chronic kidney disease mineral and bone disorder: what's new?].
    Limardo M; Pontoriero G; Locatelli F
    G Ital Nefrol; 2010; 27(3):211-4. PubMed ID: 20540007
    [No Abstract]   [Full Text] [Related]  

  • 16. Mineral metabolism: confusion to clarity.
    Bushinsky DA; Wolf MS
    Curr Opin Nephrol Hypertens; 2012 Jul; 21(4):353-4. PubMed ID: 22622652
    [No Abstract]   [Full Text] [Related]  

  • 17. [Kidney diseases and metabolic disorders-Basics and applications required for general physicians. Topics: VI. Chronic kidney disease and fragility fracture].
    Kazama JJ
    Nihon Naika Gakkai Zasshi; 2015 May; 104(5):948-52. PubMed ID: 26591344
    [No Abstract]   [Full Text] [Related]  

  • 18. [Latent hyperuricemia].
    Zöllner R
    Dtsch Med Wochenschr; 1971 Oct; 96(40):1578. PubMed ID: 5093341
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hyperuricemia in internal diseases].
    Lavicka J; Madzarovová-Nohejlová ; Chaloupková E
    Fysiatr Revmatol Vestn; 1969 Apr; 47(2):82-90. PubMed ID: 5813753
    [No Abstract]   [Full Text] [Related]  

  • 20. Association of hyperuricemia with renal outcomes, cardiovascular disease, and mortality.
    Liu WC; Hung CC; Chen SC; Yeh SM; Lin MY; Chiu YW; Kuo MC; Chang JM; Hwang SJ; Chen HC
    Clin J Am Soc Nephrol; 2012 Apr; 7(4):541-8. PubMed ID: 22300737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.